エピソード

  • Episode 43 - Integrating Emerging Therapies into Clinical Practice for Pediatric ITP: Exploring Evidence, Guidelines and Best Practices
    2025/07/07

    In this podcast, Dr. Cindy Neunert, provides expert insights into emerging data on ITP pathophysiology, diagnosis, and treatment, equipping healthcare providers with the knowledge to translate new research into clinical practice and improve pediatric patient care.

    Launch Date: July 7, 2025

    Release Date: July 7, 2025

    Expiration Date: June 30, 2026

    FACULTY

    Cindy Neunert, MD

    Division of Pediatric Hematology

    Oncology, and Stem Cell Transplantation

    Columbia University Irving Medical Center

    New York, New York

    This podcast provides accredited continuing education credits. To receive your credit, please read the accreditation information provided in this link prior to listening to this podcast.

    続きを読む 一部表示
    52 分
  • Episode 42 - Talking Hemophilia: Evolving Frontiers in Hemophilia Treatment: Patient-Focused Strategies to Improve Outcomes - Part 4: Patient Perspective in Hemophilia Care
    2025/02/04

    There has been unprecedented research progress in the treatment of hemophilia heralded by the development of non-replacement therapies, emerging factor mimetics, and novel gene therapy agents. In this podcast series, Dr. Jonathan C. Roberts and Dr. Mindy Simpson inform and guide on safely integrating recently approved agents into the treatment continuum while ensuring alignment with critical new breakthroughs and enabling patient-focused care pathways.

    Launch Date: February 4, 2025

    Release Date: February 4, 2025

    Expiration Date: January 31, 2026

    FACULTY

    Jonathan C. Roberts, MD

    Associate Medical Director

    Associate Research Director

    Bleeding and Clotting Disorders Institute

    Associate Professor of Pediatrics and Medicine

    University of Illinois College of Medicine at Peoria

    Mindy Simpson, MD

    Medical Director

    Rush Hemophilia and Thrombophilia Center

    Assistant Professor of Pediatrics in Pediatric Hematology/Oncology

    Rush University Medical Center

    This podcast provides accredited continuing education credits. To qualify for credit, please read all accreditation information here prior to listening to this episode.

    続きを読む 一部表示
    21 分
  • Episode 41 - Talking Hemophilia: Evolving Frontiers in Hemophilia Treatment: Patient-Focused Strategies to Improve Outcomes - Part 3: Relevance and Impact of Novel Agents in Hemophilia Care Paradigms
    2025/02/04

    There has been unprecedented research progress in the treatment of hemophilia heralded by the development of non-replacement therapies, emerging factor mimetics, and novel gene therapy agents. In this podcast series, Dr. Jonathan C. Roberts and Dr. Mindy Simpson inform and guide on safely integrating recently approved agents into the treatment continuum while ensuring alignment with critical new breakthroughs and enabling patient-focused care pathways.

    Launch Date: February 4, 2025

    Release Date: February 4, 2025

    Expiration Date: January 31, 2026

    FACULTY

    Jonathan C. Roberts, MD

    Associate Medical Director

    Associate Research Director

    Bleeding and Clotting Disorders Institute

    Associate Professor of Pediatrics and Medicine

    University of Illinois College of Medicine at Peoria

    Mindy Simpson, MD

    Medical Director

    Rush Hemophilia and Thrombophilia Center

    Assistant Professor of Pediatrics in Pediatric Hematology/Oncology

    Rush University Medical Center

    This podcast provides accredited continuing education credits. To qualify for credit, please read all accreditation information here prior to listening to this episode.

    続きを読む 一部表示
    6 分
  • Episode 40 - Talking Hemophilia: Evolving Frontiers in Hemophilia Treatment: Patient-Focused Strategies to Improve Outcomes - Part 2: Clinical Evidence on Novel Therapy Options in Hemophilia
    2025/02/04

    There has been unprecedented research progress in the treatment of hemophilia heralded by the development of non-replacement therapies, emerging factor mimetics, and novel gene therapy agents. In this podcast series, Dr. Jonathan C. Roberts and Dr. Mindy Simpson inform and guide on safely integrating recently approved agents into the treatment continuum while ensuring alignment with critical new breakthroughs and enabling patient-focused care pathways.

    Launch Date: February 4, 2025

    Release Date: February 4, 2025

    Expiration Date: January 31, 2026

    FACULTY

    Jonathan C. Roberts, MD

    Associate Medical Director

    Associate Research Director

    Bleeding and Clotting Disorders Institute

    Associate Professor of Pediatrics and Medicine

    University of Illinois College of Medicine at Peoria

    Mindy Simpson, MD

    Medical Director

    Rush Hemophilia and Thrombophilia Center

    Assistant Professor of Pediatrics in Pediatric Hematology/Oncology

    Rush University Medical Center

    This podcast provides accredited continuing education credits. To qualify for credit, please read all accreditation information here prior to listening to this episode.

    続きを読む 一部表示
    21 分
  • Episode 39 - Talking Hemophilia: Evolving Frontiers in Hemophilia Treatment: Patient-Focused Strategies to Improve Outcomes - Part 1: Rationale and Potential of Gene Therapy and Rebalancing Agents in Hemophilia
    2025/02/04

    There has been unprecedented research progress in the treatment of hemophilia heralded by the development of non-replacement therapies, emerging factor mimetics, and novel gene therapy agents. In this podcast series, Dr. Jonathan C. Roberts and Dr. Mindy Simpson inform and guide on safely integrating recently approved agents into the treatment continuum while ensuring alignment with critical new breakthroughs and enabling patient-focused care pathways.

    Launch Date: February 4, 2025

    Release Date: February 4, 2025

    Expiration Date: January 31, 2026

    FACULTY

    Jonathan C. Roberts, MD

    Associate Medical Director

    Associate Research Director

    Bleeding and Clotting Disorders Institute

    Associate Professor of Pediatrics and Medicine

    University of Illinois College of Medicine at Peoria

    Mindy Simpson, MD

    Medical Director

    Rush Hemophilia and Thrombophilia Center

    Assistant Professor of Pediatrics in Pediatric Hematology/Oncology

    Rush University Medical Center

    This podcast provides accredited continuing education credits. To qualify for credit, please read all accreditation information here prior to listening to this episode.

    続きを読む 一部表示
    22 分
  • Episode 38 - Conversations in IFN-y Driven Diseases: Decoding the Gamma Signal - Part 5: Secondary HLH/MAS & Updates from ASH
    2025/01/20

    Conversations in IFN-y explores the latest advancements in understanding and managing secondary hemophagocytic lymphohistiocytosis (HLH) and macrophage activation syndrome (MAS), with updates from ASH 2024. Featuring discussions by leading experts, the educational activity covers breakthroughs in diagnostic technologies. Topics covered include AI-based histology models and PET/CT imaging, therapeutic innovations such as emapalumab and reduced-intensity conditioning for HSCT. The implications of these findings for improving outcomes in diverse patient populations, including malignancy- and pregnancy-associated HLH will also be discussed.

    Launch Date: January 9, 2025

    Release Date: January 9, 2025

    Expiration Date: December 31, 2025

    FACULTY

    Pui Lee, MD

    Assistant Professor of Pediatrics

    Boston Childrens Hospital

    Ashish Kumar, MD, PhD

    Professor of Pediatrics

    Cincinnati Children's Hospital Medical Center

    Alexei Grom, MD

    Professor of Pediatrics

    Research Director

    Division of Rheumatology

    Cincinnati Children’s Hospital Medical Center

    This podcast provides accredited continuing education credits. To receive your credit, please read the accreditation information provided in this link prior to listening to this podcast.

    続きを読む 一部表示
    47 分
  • Epsiode 37 - What’s New Doc? End of the Year Updates on CAR T-cell Therapy in Multiple Myeloma
    2025/01/20

    What’s New Doc?: CAR T-cells in Multiple Myeloma, highlights key studies and publications from 2024 on the use of these agents in earlier lines of treatment. Dr. Mikhael details how approved and emerging CAR T cell agents in multiple myeloma will impact the treatment landscape and how to better integrate these agents to enable improved outcomes among patients.

    Launch Date: December 19, 2024

    Release Date: December 19, 2024

    Expiration Date: November 30, 2025

    FACULTY

    Joseph Mikhael, MD, MEd, FRCPC, FACP

    Professor, Applied Cancer Research and Drug Discovery, Translational Genomics Research Institute (TGen), City of Hope Cancer Center

    Chief Medical Officer, International Myeloma Foundation

    Consultant Hematologist and Director, Myeloma Research, Phase 1 Program, HonorHealth Research Institute

    Adjunct Professor, College of Health Solutions, Arizona State University

    This podcast provides accredited continuing education credits. To receive your credit, please read the accreditation information provided in this link prior to listening to this podcast.

    続きを読む 一部表示
    19 分
  • Episode 36 - Conversations in IFN-y Driven Diseases: Decoding the Gamma Signal - Part 4: Updates from ACR Convergence 2024
    2025/01/20

    In this Conversations in IFN-y podcast episode, emerging data from the 2024 ACR meeting is discussed, highlighting advancements in understanding genetic drivers, cytokine dynamics, and biomarkers like IL-18 and CXCL9 for improved diagnosis and monitoring. Expert insights explore new findings on liver and lung pathology in MAS, as well as updates on therapeutic innovations, including JAK inhibitors and emapalumab, and their roles in enhancing patient outcomes. Practical strategies are provided for integrating the latest research and cutting-edge diagnostics into clinical practice.

    Launch Date: December 19, 2024

    Release Date: December 19, 2024

    Expiration Date: November 30, 2025

    FACULTY

    Pui Lee, MD

    Assistant Professor of Pediatrics

    Boston Children's Hospital

    Alexei Grom, MD

    Professor of Pediatrics

    Research Director

    Division of Rheumatology

    Cincinnati Children’s Hospital Medical Center

    This podcast provides accredited continuing education credits. To receive your credit, please read the accreditation information provided in this link prior to listening to this podcast.

    続きを読む 一部表示
    47 分